Evidence map›Paper›PMID 39857747›Full record

ArticleBiomedicines2025

Impact of First- and Second-Generation Tyrosine Kinase Inhibitors on the Development of Graft-Versus-Host Disease in Individuals with Chronic Myeloid Leukemia: A Retrospective Analysis on Behalf of the Polish Adult Leukemia Group.

Ugo Giordano, Agnieszka Piekarska, Witold Prejzner, Lidia Gil, Jan Maciej Zaucha, Joanna Kujawska, Zuzanna Dybko, Krzysztof Dudek, Sebastian Giebel, Jarosław Dybko

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ugo GiordanoDepartment and Clinic of Endocrinology and Internal Medicine, Wrocław University Hospital, 50-367 Wroclaw, Poland.ORCID 0009-0000-8735-3076
Agnieszka PiekarskaDepartment of Hematology and Transplantology, Medical University of Gdansk, 80-210 Gdansk, Poland.ORCID 0000-0002-1593-8005
Witold PrejznerDepartment of Hematology and Transplantology, Medical University of Gdansk, 80-210 Gdansk, Poland.
Lidia GilDepartment of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, 60-569 Poznan, Poland.
Jan Maciej ZauchaDepartment of Hematology and Transplantology, Medical University of Gdansk, 80-210 Gdansk, Poland.
Joanna KujawskaDepartment of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, 60-569 Poznan, Poland.
Zuzanna DybkoFaculty of Medicine, Wroclaw Medical University, 50-367 Wrocław, Poland.
Krzysztof DudekFaculty of Mechanical Engineering, Wroclaw University of Science and Technology, Wybrzeze Wyspianskiego 27, 50-370 Wroclaw, Poland.ORCID 0000-0002-9442-989X
Sebastian GiebelDepartment of Bone Marrow Transplantation and Oncohematology, Gliwice Branch, Maria Sklodowska-Curie National Research Institute of Oncology, 44-102 Gliwice, Poland.
Jarosław DybkoDepartment of Hematology and Cellular Transplantation, Lower Silesian Oncology Center, 53-413 Wroclaw, Poland.ORCID 0000-0003-3555-2887

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

allogeneic hematopoietic stem cell transplantationchronic myeloid leukemiadasatinibimatinibnilotinibtyrosine kinase inhibitors

Identifiers

PMID39857747
PMCPMC11759780

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.